Outpatient Treatment for Mild Acute Diverticulitis: Antibiotics vs. No Antibiotics
A study compares outpatient treatment with and without antibiotics for mild acute diverticulitis, aiming to assess differences in admission rates and outcomes, providing evidence for optimizing management approaches in clinical practice.
July 2022
Adolescent Cannabis Use and Neurodevelopmental Impact: Implications for Brain Health
Adolescent cannabis use has lasting effects on brain development and behavior, highlighting the importance of early intervention and preventive measures to mitigate the neurodevelopmental impact of cannabis use during adolescence.
April 2022
Antibiotic Therapy for Prosthetic Joint Infection: Comparative Efficacy and Safety
Open-label randomized trial compares the efficacy and safety of 6 weeks versus 12 weeks of antibiotic therapy for prosthetic joint infection, providing evidence-based recommendations for treatment duration and optimizing clinical outcomes in affected patients.
January 2022
Nitazoxanide for COVID-19 Treatment: Regulatory Status Update
Emergency use authorization for nitazoxanide as a potential treatment for COVID-19 is requested from the FDA in the US, signaling ongoing efforts to repurpose existing drugs for combating the pandemic and expanding therapeutic options for affected individuals.
January 2022
Antipsychotic-Cardiovascular Drug Interactions: Polypharmacy Risks
Polypharmacy involving antipsychotics and cardiovascular drugs increases the risk of potential adverse drug interactions, highlighting the importance of medication reconciliation and monitoring in patients receiving multiple pharmacological agents.
August 2021
Safety of Psychotropic Drugs in COVID-19 Patients: Clinical Considerations and Management Strategies
Understanding the clinically relevant safety profiles of psychotropic drugs in patients with COVID-19 is essential for optimizing treatment outcomes and minimizing potential adverse effects, highlighting the importance of tailored pharmacological interventions and close monitoring in this patient population.
Februery 2021
